ArticleFrontiers in pediatrics2026
PROMISE-impact of maternal and neonatal risk factors on the respiratory outcome of extremely preterm infants following PPROM in the second trimester of pregnancy.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Maternal and Neonatal Determinants of Respiratory Outcome Following Second-Trimester PPROM: A Multi-Domain Machine Learning Analysis.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prolonged preterm premature rupture of membranes (PPROM) in the second trimester is associated with heterogeneous neonatal respiratory outcomes, ranging from mild transitional respiratory impairment to dry lung syndrome (DL), pulmonary hypoplasia (PH), bronchopulmonary dysplasia (BPD) and death. Risk assessment is challenging because outcomes are influenced by both gestational maturity and PPROM-specific exposures. This study aimed to evaluate respiratory outcomes after prolonged PPROM using a multifactorial and longitudinal approach that integrates gestational age, amniotic fluid status, inflammatory signs, and maternal characteristics. Methods: We retrospectively analyzed 66 pregnancies with second-trimester PPROM and prolonged latency. Short-term respiratory outcomes were classified as no respiratory disease, dry lung (DL), or pulmonary hypoplasia (PH); neonatal death and BPD were also assessed. Gestational age (GA) at PPROM and at birth were analyzed using ordered groupings with trend testing. Multivariable logistic regression was used to identify independent risk factors. Serial weekly measurements of the single deepest vertical pocket (SDP) were evaluated longitudinally using repeated-measures analysis to compare amniotic fluid trajectories between outcome groups. Results: Respiratory morbidity and death decreased stepwise with increasing GA at PPROM and GA at birth. Lower SDP values were consistently associated with PH, BPD, and death, particularly when median SDP was <2 cm. Longitudinal analysis demonstrated persistently lower SDP values in pregnancies resulting in PH, without evidence of differing SDP trajectories over time between groups. Inflammatory signs were associated with BPD, while maternal age and GA at PPROM were associated with PH and death. DL showed a distinct pattern, with weaker associations to gestational age and amniotic fluid parameters compared with PH. Conclusion: Outcomes after prolonged second-trimester PPROM reflect a multifactorial risk profile in which gestational maturity, amniotic fluid impairment, inflammatory status, and maternal characteristics interact. Integrating longitudinal ultrasound data with gestational-age-based risk stratification can improve counseling and support individualized management strategies in PPROM pregnancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.